Medicine and Dentistry
Patient
100%
Non Small Cell Lung Cancer
44%
Randomized Controlled Trial
39%
Cost-Effectiveness Analysis
32%
Quality Adjusted Life Year
32%
Health Care Cost
30%
Therapeutic Procedure
28%
Chemotherapy
26%
Exercise
25%
Physical Activity
25%
Dementia
25%
Lung Cancer
18%
Disease
16%
Noninvasive Ventilation
16%
Health
16%
Ventilator Weaning
13%
Intensive Care
13%
Malignant Neoplasm
12%
Cognitive Defect
12%
Mandibular Third Molar
12%
B-Cell Chronic Lymphocytic Leukemia
12%
Molar Tooth
12%
Adult
12%
Erlotinib
12%
Oncolytic Adenovirus
12%
Dental Caries
12%
Saracatinib
12%
Primary Peritoneal Cancer
12%
Cell Therapy
12%
Coxsackie Virus and Adenovirus Receptor
12%
Platinum
12%
Cell Cycle Regulation
12%
Receptor Expression
12%
Extubation
12%
Gefitinib
12%
Glioblastoma
12%
Health Status
12%
Phase II Trials
12%
Spontaneous Remission
10%
Artificial Respiration
10%
Radiation Therapy
9%
Arm
8%
Minimal Residual Disease
8%
Toxicity
7%
Clinical Trial
7%
Weaning
7%
Chemoradiotherapy
7%
Vinorelbine
6%
Monte Carlo Method
6%
Mortality
6%
Nursing and Health Professions
Cost Effectiveness Analysis
31%
Quality Adjusted Life Year
19%
Quality of Life
17%
Standard
8%
Economic Evaluation
7%
